Vitamin D compounds for people with chronic kidney disease requiring dialysis-Reference-Cited by-同舟云学术

Vitamin D compounds for people with chronic kidney disease requiring dialysis

Published:2009-10-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Palmer Suetonia C¹,McGregor David O²,Craig Jonathan C³,Elder Grahame⁴,Macaskill Petra⁵,Strippoli Giovanni FM⁶

Affiliation:

1. Brigham and Women's Hospital, Harvard Medical School; Renal Division; Harvard Institute of Medicine, Room 550 4 Blackfan Street Boston MA USA 02115

2. Christchurch Hospital; Department of Nephrology; Private Bag 4710 Christchurch New Zealand 8001

3. School of Public Health, The University of Sydney; Centre for Kidney Research, The Children's Hospital at Westmead; Locked Bag 4001 Westmead NSW Australia 2145

4. Garvan Institute of Medical Research; Bone and Mineral Program; 384 Victoria St Darlinghurst NSW Australia 2010

5. School of Public Health; Screening and Test Evaluation Program (STEP); University of Sydney Edward Ford Building, A27 Sydney NSW Australia 2006

6. The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005633.pub2/fullpdf

Reference124 articles.

1. Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism;Akiba;American Journal of Kidney Diseases,1998

2. Falecalcitriol (FC), but not alfacalcidol (AC), suppresses secondary hyperparathyroidism in hemodialysis (HD) patients (Pts) - a well-controlled crossover study [abstract];Akiba;Nephrology,1997

3. Suppressive effect of 22-oxacalcitriol (OCT) on secondary hyperparathyroidism (2 HPT) of hemodialysis (HD) patients. A double-blind comparison among four doses [abstract];Akizawa;Journal of the American Society of Nephrology,1996

4. Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism;Akizawa;Therapeutic Apheresis & Dialysis,2004

5. 'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study. [erratum appears in Nephron 1998 Aug;79(4):509];Bacchini;Nephron,1997

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis;American Journal of Kidney Diseases;2023-11

2. The effects of vitamin D on all-cause mortality in different diseases: an evidence-map and umbrella review of 116 randomized controlled trials;Frontiers in Nutrition;2023-06-22

3. Comparison of the effect of vitamin D levels on foot movements in patients receiving hemodialysis treatment for renal failure;Journal of Medical Topics and Updates;2023-04-30

4. Disorders of Bone Mineral Metabolism in Chronic Kidney Disease;Pediatric Kidney Disease;2023

5. Vitamina D: una mirada moderna como coadyuvante en el dolor;Multidisciplinary Pain Journal;2023